HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Ubiquiti Inc. (UI) Investors with Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Law Violations

PR Newswire

SAN FRANCISCO, April 1, 2021/PRNewswire/ — Hagens Berman urges Ubiquiti Inc. (NYSE: UI) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.


Visit:


www.hbsslaw.com/investor-fraud/UI 


Contact an Attorney Now:


[email protected] 


                                             844-916-0895


Ubiquiti Inc. (NYSE: UI) Investigation:

The investigation focuses on whether Ubiquiti accurately reported the nature and scope of a recent security breach incident.

On Jan. 11, 2021, Ubiquiti urged customers to change their passwords and enable multi-factor authentication after it became aware of unauthorized access to certain of its information technology systems hosted by a third-party cloud provider. The company, however, downplayed the seriousness of the incident, advising its customers that it was not currently aware of evidence of access to databases that host user data.

But on March 30, 2021, KrebsonSecurity published an article entitled, “Whistleblower: Ubiquiti Breach ‘Catastrophic,'” reporting that a Ubiquiti security professional who helped the company respond to the two-month breach beginning in December 2020 informed Krebs that the breach was catastrophically worse than reported. Krebs quoted the source as saying “[t]he breach was massive, customer data was at risk, access to customers’ devices deployed in corporations and homes around the world was at risk.” The source also reportedly said the Jan. 11, 2021 breach disclosure was “downplayed and purposefully written to imply that a 3rd party cloud vendor was at risk and that Ubiquiti was merely a casualty of that, instead of the target of the attack.” In reality, according to Krebs‘ reporting, the attackers gained administrative access to Ubiquiti’s servers.

In response, the price of Ubiquiti shares fell over 16% during intraday trading on March 31, 2021.

“We’re focused on investors’ losses and whether Ubiquiti intentionally misrepresented the security of a core business,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are an
Ubiquiti
investor and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers:
Persons with non-public information regarding Ubiquiti should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email

[email protected]

.



About Hagens Berman




Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.


Contact:



Reed Kathrein, 844-916-0895

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hagens-berman-national-trial-attorneys-encourages-ubiquiti-inc-ui-investors-with-losses-to-contact-its-attorneys-now-firm-investigating-possible-securities-law-violations-301261098.html

SOURCE Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Amdocs Limited (DOX) Investors with Losses to Contact Its Attorneys Now, Analyst Calls Shares “Uninvestable”

PR Newswire

SAN FRANCISCO, April 1, 2021 /PRNewswire/ — Hagens Berman urges Amdocs Limited (NASDAQ: DOX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

Visit:  
www.hbsslaw.com/investor-fraud/DOX


Contact an Attorney Now:
 [email protected]
                                             844-916-0895

Amdocs Limited (NASDAQ: DOX) Investigation:
The investigation focuses on the accuracy of Amdocs’ reported financial results.

In past quarters, Amdocs repeatedly touted its strong sequential revenue growth, margins, and strong balance sheet.

But on March 31, 2021, these and other company representations were brought into question when Jehoshaphat Research published a scathing report entitled, “Where Did Amdocs’ Profits And Auditors Go?”, concluding that Amdocs is “a massive financial deception” and “the stock is uninvestable.”

Based on a review of Amdocs international subsidiaries’ filings overseas, Jehoshaphat‘s claims Amdocs has overstated profits by as much as 50% that its reported profit margins are “wildly” inflated, and approximately 1/3 of Amdocs’ stated cash is unavailable for use. Jehoshaphat reported that former employee and direct competitor interviews confirmed its findings that Amdocs “has been losing business for years but has made up for these losses by inflating financials, sometimes to a point beyond recognition by the country managers.” Jehoshaphat also raised concerns about the company subsidiaries’ auditor resignations during the last two years.

In response, the price of Amdocs shares fell over 11% on March 31, 2021, wiping out hundreds of millions of dollars of shareholder value.

“We’re focused on investors’ losses and whether Amdocs cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are an Amdocs investor and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Amdocs should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].


About Hagens Berman


Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein
844-916-0895

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hagens-berman-national-trial-attorneys-encourages-amdocs-limited-dox-investors-with-losses-to-contact-its-attorneys-now-analyst-calls-shares-uninvestable-301261092.html

SOURCE Hagens Berman Sobol Shapiro LLP

Greg Goodman Returns to Singing News Radio to Host Top 20 Weekly Countdown

Greg Goodman Returns to Singing News Radio to Host Top 20 Weekly Countdown

IRVING, Texas–(BUSINESS WIRE)–Salem Media Group, Inc. (NASDAQ: SALM) announced today that Southern Gospel personality Greg Goodman is returning to Singing News Radio to host the Top 20 Weekly Countdown. Goodman originated the program as the Singing News Top 10 during his tenure as program director of the network. Goodman along with Rodney Baucom developed the show into its current Top 20 format. Singing News Radio General Manager Kevin Anderson stated, “Greg Goodman is one of the most respected radio personalities in Southern Gospel. We are excited to have him return to the network to host the Top 20 Countdown.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210401005964/en/

Greg Goodman (Photo: Business Wire)

Greg Goodman (Photo: Business Wire)

When asked about his return to SNR to host the countdown, Goodman said, “I’m excited to be working with my friends at Singing News Radio again. I’m honored to have this opportunity to host the countdown.” Goodman’s first show will be Easter weekend.

The Singing News Top 20 Weekly Countdown is heard on more than 140 radio stations each week in the US and Canada. For more information on the Singing News Top 20 Weekly Countdown, contact Greg Roberson at: [email protected].

ABOUT SALEM MEDIA GROUP:

Salem Media Group is America’s leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. Learn more about Salem Media Group, Inc. at www.salemmedia.com, Facebook and Twitter.

Evan D. Masyr

Executive Vice President and Chief Financial Officer

(805) 384-4512

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Entertainment Communications Consumer Music Religion Publishing

MEDIA:

Logo
Logo
Photo
Photo
Greg Goodman (Photo: Business Wire)

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Renewable Energy Group, Inc. Investors to Secure Counsel Before Important May 3 Deadline – REGI

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Renewable Energy Group, Inc. Investors to Secure Counsel Before Important May 3 Deadline – REGI

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Renewable Energy Group, Inc. (NASDAQ: REGI) between May 3, 2018 and February 25, 2021, inclusive (the “Class Period”), of the important May 3, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Renewable Energy Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Renewable Energy Group class action, go to http://www.rosenlegal.com/cases-register-2048.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) due to failures in the diesel additive system, petroleum diesel was not periodically added to certain loads by the Company and was instead added by the Company’s customers; (2) as a result, Renewable Energy Group was not the proper claimant for certain biodiesel tax credit (BTC) payments on biodiesel it sold between January 1, 2017 and September 30, 2020; (3) as a result, Renewable Energy Group’s revenue and net income were overstated for certain periods; (4) there was a material weakness in the Company’s internal control over financial reporting related to the purchase and use of the petroleum diesel gallons when blending with biodiesel; and (5) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Renewable Energy Group class action, go to http://www.rosenlegal.com/cases-register-2048.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: China United States Hong Kong North America Asia Pacific Taiwan New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Quidel Partners With San Diego Padres Organization for COVID-19 Testing

Quidel Partners With San Diego Padres Organization for COVID-19 Testing

Frequent COVID-19 Testing Program Keeps Padres Front Office Team and Petco Park Staff Feeling “Safe At Home”

Quidel Named “Official Diagnostics Partner” for the MLB Franchise

SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that after several months supporting the Padres Front Office’s efforts to reopen safely, Quidel has been chosen as “Official Diagnostics Partner” of the San Diego Padres Major League Baseball (MLB) franchise. The company will be providing excellent performing Sofia® 2 instruments and Sofia® SARS Antigen tests for use by the Padres medical staff for the Front Office Team, Event Staff and our Petco Park partners including Aramark, DNC, Elite and others.

“Our partnership with Quidel has been critical to enabling today’s Opening Day at Petco Park and helping bring the excitement of Major League Baseball back to Padres fans,” said Padres Chief Executive Officer Erik Greupner. “Quidel’s rapid antigen COVID-19 tests provide results in just 15 minutes, giving our Padres staff and Petco Park partners the confidence to feel ‘Safe At Home’ at our ballpark.”

“The Quidel Team has been at the forefront of the fight against the COVID-19 pandemic since the start and was the first to introduce rapid antigen tests to empower providers with a rapid solution for COVID-19 diagnosis and helping to limit the spread of COVID-19 in our community,” said Douglas Bryant, president and CEO of Quidel Corporation. “San Diego is our home, and it gives our people tremendous pride to be the Official Diagnostics Partner of the Padres and to help ensure the entire Petco Park Team is ‘Safe At Home.’ Go Padres!”

Headquartered in San Diego, Quidel is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com.

About the Sofia 2 SARS Antigen FIA Test

The Sofia SARS Antigen FIA has not been FDA cleared or approved, but has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. No CLIA Waiver will be required for organizations administering the test. This assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner.

View our story told by our people at www.quidel.com/ourstory.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws that involve material risks, assumptions and uncertainties. Many possible events or factors could affect our future results and performance, such that our actual results and performance may differ materially from those that may be described or implied in the forward-looking statements. As such, no forward-looking statement can be guaranteed. Differences in actual results and performance may arise as a result of a number of factors including, without limitation: the impact and duration of the COVID-19 global pandemic; competition from other providers of diagnostic products; our ability to accurately forecast demand for our products and products in development, including in new market segments; our ability to develop new technologies, products and markets and to commercialize new products; our reliance on sales of our COVID-19 and influenza diagnostic tests; our reliance on a limited number of key distributors; quantity of our product in our distributors’ inventory or distribution channels; changes in the buying patterns of our distributors; the financial soundness of our customers and suppliers; lower than anticipated market penetration of our products; third-party reimbursement policies and potential cost constraints; our ability to meet demand for our products; interruptions, delays or shortages in the supply of raw materials, components and other products and services; failures in our information technology and storage systems; our exposure to data corruption, cyber-based attacks, security breaches and privacy violations; international risks, including but not limited to, economic, political and regulatory risks; continuing worldwide political and social uncertainty; our development, acquisition and protection of proprietary technology rights; intellectual property risks, including but not limited to, infringement litigation; the loss of Emergency Use Authorizations for our COVID-19 products and failures or delays in receipt of reviews or regulatory approvals, clearances or authorizations for new products or related to currently-marketed products by the U.S. Food and Drug Administration (the “FDA”) or other regulatory authorities or loss of any previously received regulatory approvals, clearances or authorizations or other adverse actions by regulatory authorities; our contracts with government entities involve future funding, compliance and possible sanctions risks; product defects; changes in government policies and regulations and compliance risks related thereto; our ability to manage our growth strategy and successfully identify, acquire and integrate potential acquisition targets or technologies and our ability to obtain financing; our acquisition of Alere’s Triage® business presents certain risks to our business and operations; the level of our deferred payment obligations; our exposure to claims and litigation that could result in significant expenses and could ultimately result in an unfavorable outcome for us, including the ongoing litigation between us and Beckman Coulter, Inc.; we may need to raise additional funds to finance our future capital or operating needs; our debt, deferred and contingent payment obligations; competition for and loss of management and key personnel; business risks not covered by insurance; changes in tax rates and exposure to additional tax liabilities or assessments; and provisions in our charter documents and Delaware law that might delay or impede stockholder actions with respect to business combinations or similar transactions. Forward-looking statements typically are identified by the use of terms such as “may,” “will,” “should,” “might,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “goal,” “project,” “strategy,” “future,” and similar words, although some forward-looking statements are expressed differently. The risks described in reports and registration statements that we file with the Securities and Exchange Commission from time to time, should be carefully considered, including those discussed in Item 1A, “Risk Factors” and elsewhere in our Annual Report on Form 10 K for the year ended December 31, 2020 and in our subsequent Quarterly Reports on Form 10 Q. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date of this press release. Except as required by law, we undertake no obligation to publicly release any revision or update of these forward-looking statements, whether as a result of new information, future events or otherwise.

Quidel Contact:

Quidel Corporation

Randy Steward

Chief Financial Officer

(858) 552-7931

Investors Contact:

Quidel Corporation

Ruben Argueta

(858) 646-8023

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Baseball Biotechnology Sports Medical Supplies Health Medical Devices Infectious Diseases Other Health

MEDIA:

Logo
Logo

PotlatchDeltic Scheduled to Release First Quarter 2021 Earnings on April 26, 2021

PotlatchDeltic Scheduled to Release First Quarter 2021 Earnings on April 26, 2021

SPOKANE, Wash.–(BUSINESS WIRE)–
PotlatchDeltic Corporation (NASDAQ: PCH) will release first quarter earnings on Monday, April 26, after the market closes. The company will hold a live conference call and webcast on Tuesday, April 27 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) to discuss the results.

Investors may access the webcast at www.potlatchdeltic.com by clicking on the Investors link or by conference call at 1-833-968-2227 for U.S./Canada and 1-778-560-2697 for international callers. Participants will be asked to provide conference I.D. number 3825708.

A replay of the conference call will be available two hours following the call until May 5, 2021 by calling 1-800-585-8367 for U.S./Canada or 1-416-621-4642 for international callers. Callers must enter conference I.D. number 3825708 to access the replay.

About PotlatchDeltic

PotlatchDeltic (NASDAQ:PCH) is a leading Real Estate Investment Trust (REIT) that owns approximately 1.8 million acres of timberlands in Alabama, Arkansas, Idaho, Louisiana, Minnesota and Mississippi. Through its taxable REIT subsidiary, the company also operates six sawmills, an industrial-grade plywood mill, a residential and commercial real estate development business and a rural timberland sales program. PotlatchDeltic, a leader in sustainable forest practices, is committed to environmental and social responsibility and to responsible governance. More information can be found at www.potlatchdeltic.com.

(Investors)

Jerry Richards

509-835-1521

(Media)

Anna Torma

509-835-1558

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Forest Products Residential Building & Real Estate Commercial Building & Real Estate Natural Resources Construction & Property REIT

MEDIA:

Logo
Logo

Fancamp Announces Termination for Cause of Mr. Peter H. Smith’s Consulting Agreement; Provides Facts on Continued Misleading Statements from Activists

Fancamp Announces Termination for Cause of Mr. Peter H. Smith’s Consulting Agreement; Provides Facts on Continued Misleading Statements from Activists

VANCOUVER, British Columbia–(BUSINESS WIRE)–
Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) today announced that the Board of Directors (the “Board”) has terminated the consulting agreement between Fancamp and Mr. Peter H. Smith for cause effective immediately. The Board has also requested that Mr. Smith resign from his role as director promptly.

The Board has provided Mr. Smith with multiple opportunities to act in a proper manner and adhere to appropriate governance practices, but he has refused. Notably, the Board has repeatedly tried to engage with Mr. Smith over the last few months to address the issues that led to his termination. Mr. Smith has not cooperated with these efforts, and instead, continued to hide and withhold information from the Board and management, in addition to numerous other grave issues.

The Board has also made multiple attempts to reason with Mr. Smith and work with him in a cooperative manner. Instead, Mr. Smith has continued to be disruptive and go against the best of interests of the Corporation in order to regain his former position with Fancamp. The Corporation cannot justify spending shareholders’ money to pay an individual who not only is refusing to do any work for the Corporation, but instead, is actively working against shareholders’ interests. The Board has carefully considered the situation and the context, and has determined that it is justified to terminate the consulting agreement and that, as such, Mr. Smith is not entitled to any payouts.

As the Corporation continues to investigate and examine the conduct of Mr. Smith in relation to the numerous issues listed below, the Corporation reserves all of its legal rights in connection with Mr. Smith and will consider any such measures as are appropriate on behalf of its shareholders to address potential misconduct, including through the courts if necessary.

REASONS FOR TERMINATION:

Mr. Smith was terminated for cause due to, among others, the following actions, all of which were detrimental to the Corporation and its shareholders:

  • He repeatedly ignored the instructions of the Board and acted against the Board’s specific direction;
  • He failed to comply with his duty of confidentiality and to comply with applicable legislation by disclosing non-public material information, including information about the December 31, 2020 private placement and the proposed business combination with ScoZinc Mining Ltd. (“ScoZinc”) (the “Transaction”);
  • He failed to comply with his duty of loyalty by repeatedly refusing to cooperate with the Board and management of Fancamp, and recently, by withholding information in his possession to management following him stepping down as president and CEO in August 2020; and
  • He failed to provide the services outlined in the consulting agreement; rather than acting for the Corporation, he acted against the interests of the Corporation by withholding information and not cooperating with management’s efforts, which resulted in delaying the technical review and causing setbacks and unnecessary costs to the Corporation

Peter Smith: Breach of Fiduciary Duty as a Director

As a director, Mr. Smith also has a fiduciary duty to Fancamp’s shareholders and was required to follow all applicable legislation, including ensuring the confidentiality of non-public material information. Instead, Mr. Smith blatantly disclosed confidential information by issuing a public statement on December 22, 2020, which included, among others, details discussed during Board meetings at Fancamp as well as a private placement that had been approved in principle by the Board, but had not yet been announced. The Corporation closed and announced the private placement on December 31, 2020.

Mr. Smith’s unlawful disclosure on December 22, 2020 of non-public material information in connection with the potential private placement may have jeopardized the integrity of the securities market and affected the market price or trading of Fancamp’s securities. As such, the Board has notified the British Columbia Securities Commission of Mr. Smith’s actions.

IN RESPONSE TO THE FALSE CLAIMS BY MR. SMITH, FANCAMP WOULD LIKE TO REMIND SHAREHOLDERS OF THE FACTS:

The Transaction Will Unlock Value for Fancamp Shareholders; Mr. Smith’s Misleading Statements Regarding the Transaction is to Protect Self-Interests

Mr. Smith has repeatedly made false allegations against the Corporation and spread misinformation about the Transaction.

Contrary to Mr. Smith’s misleading statements:

  • Fancamp shareholders will emerge from this Transaction with a greatly enhanced opportunity to create value. The combination of Fancamp and ScoZinc takes two significantly undervalued companies and creates a larger, stronger entity that will be in a better position to attract new investments for growth and funding for strategic initiatives. The combined entity will also be well-positioned to capitalize on the global demand for zinc, which is expected to double by 2050.
  • The Transaction was the result of a transparent, credible and thorough process with input from Fancamp’s independent financial and legal advisors. All members of the Board – including Mr. Smith – received a copy of the final fairness opinion from Ernst & Young LLP, which stated that the consideration to be paid in connection with the Transaction is fair for Fancamp.

Shareholders can read all the facts about the Transaction here.

There will be No New Controlling Positions on the Board After the Close of the Transaction

Contrary to Mr. Smith’s misleading statements, there will be no new controlling positions after the Transaction closes.

The composition of the Board after the Transaction will also be up to Fancamp shareholders. As stated in the February 18, 2021 and March 18, 2021 press releases, as well as in the Transaction agreement (a copy of which is available on SEDAR), after the Transaction closes, Messrs. Mark Haywood (president and chief executive officer of ScoZinc) and Christopher Hopkins (director of ScoZinc) will be nominated to join the Fancamp Board of Directors at the Corporation’s next annual general meeting (“AGM”). Shareholders will be able to vote on these nominees in due course.

Mr. Smith Lacks Business Judgment and Strategy, and Withheld Information from the Board

Under Mr. Smith’s tenure at Fancamp, there was no focus or rigorous approach to drilling campaigns and no discovery was ever made. Instead, Mr. Smith, often without the knowledge or approval of the Board, or in contravention to its instructions, or not in accordance therewith, embarked on endless and, in retrospect, often poorly executed staking exercises that, in the end, delivered nothing to shareholders. While expensive projects were undertaken, there was no appreciation in the Corporation’s share price.

An investigation by the Board pertaining to expenditures made between 2010 and 2019 uncovered that significant amounts were spent on operating, exploration, and development expenses, with no tangible advancement on any of the properties of Fancamp. Furthermore, a large portion of these expenditures had to be written off, meaning that they had no value to shareholders or to the Corporation.

To offset the poor execution of these projects, Mr. Smith sold off, between May 2018 and July 2020, 4.8 million shares of Champion Iron Limited (TSX: CIA) (“Champion”) at low prices for proceeds of C$6.8 million. Such sales were at times in direct contravention with the instructions of the Board.

A recent example of Mr. Smith’s typical approach was an expenditure of approximately C$600,000 in Virginia, United States, on geological activities which had no underlying mineral property. This expenditure was committed without the prior knowledge and approval of the Board. Since there was no underlying property associated with these expenses, the Corporation was subsequently forced to write off all of it.

Even after he stepped down, Mr. Smith continued to withhold information from the Board. Consequently, the Corporation was unable to conduct the appropriate technical reviews of its properties, forcing the Corporation to incur additional costs and experience setbacks in completing its review. In short, Mr. Smith’s actions have resulted in numerous delays and unnecessary expenses.

Mr. Smith Has a Complete Disregard for Good Corporate Governance

Subsequent to numerous discussions from the Board to Mr. Smith on improving corporate governance and to heed guidance from the Board, three directors resigned in 2018 as Mr. Smith refused to cooperate, with the remaining directors continuing to press Mr. Smith for proper corporate governance. Despite repeated pleas to improve its management approach, Mr. Smith did not listen and failed to make improvements, and instead, pursued with the detrimental actions stated above. Notably, before he stepped down, he continued to defy the Board’s repeated and reasonable requests to obtain formal budgets and to approve expenses and projects.

Mr. Smith has and continues to refuse to abide with the Board’s instructions and to cooperate with current management. Despite his obligations under his consulting agreement and repeated requests, he withheld company information, causing significant challenges and delays in conducting technical reviews which would help advance the Corporation forward. Instead, due to Mr. Smith’s self-serving actions, the Corporation was forced to incur additional costs and delays.

FANCAMP REMAINS FOCUSED ON THE FUTURE

Despite Mr. Smith’s self-serving actions to initiate an unnecessary, costly and time-consuming proxy contest against the Corporation, Fancamp remains focused on executing its three-pronged strategy for growth and completing the transformational Transaction to create significant value for Fancamp shareholders.

Fancamp believes the Transaction will create tremendous value and sustainable growth for the Corporation and to its shareholders over the medium to long-term. Among the many benefits, the Transaction will enable Fancamp to plan the restart of the commercial production of ScoZinc’s Scotia Mine, a high-quality, past-producing facility with a fully built infrastructure in a stable, premier jurisdiction near Halifax, Nova Scotia, which is expected to create significant cashflow for the Corporation.

Advisors

Lavery, de Billy, L.L.P. is serving as legal advisor to Fancamp. Kingsdale Advisors is acting as strategic shareholder and communications advisor to Fancamp.

About Fancamp Exploration Ltd. (TSX-V: FNC)

Fancamp is a growing Canadian mineral exploration corporation dedicated to its value-added strategy of advancing mineral properties through exploration and development. The Corporation owns numerous mineral resource properties in Quebec, Ontario and New Brunswick, including gold, rare earth metals, strategic and base metals, zinc, chromium, titanium and more. Fancamp is also building on the industrial possibilities inherent in dealing with some of these materials, notable being the development of its Titanium technology strategy. It has recently announced the acquisition of ScoZinc, a Canadian exploration and mining corporation that has full ownership of the Scotia Mine and related facilities near Halifax, Nova Scotia, as well as several prospective exploration licenses in surrounding regions. The Corporation is managed by a new and focused leadership team with decades of mining, exploration and complementary technology experience.

Forward-looking Statements

This news release includes certain forward-looking statements which are not comprised of historical facts. Forward-looking statements include estimates and statements that describe both companies’ future plans, objectives or goals, including words to the effect that both companies or their respective management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to Fancamp, Fancamp provides no assurance that actual results will meet the management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes, but is not limited to, the Corporation’s annual general meeting, objectives, goals or future plans, statements, potential mineralization, exploration and development results, the estimation of mineral resources, exploration and mine development plans, timing of the commencement of operations, estimates of market conditions, future financial results or financing opportunities. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Fancamp’s expectations include, among others, political, economic, environmental and permitting risks, mining operational and development risks, litigation risks, notably in connection with the termination of Mr. Smith’s consulting agreement, regulatory restrictions, environmental and permitting restrictions and liabilities, the inability of both companies to satisfy the conditions precedent to complete the Transaction, the inability to obtain the necessary regulatory and third-party approvals for the Transaction, the inability to start production at the Scotia Mine, the inability of Fancamp to realize the anticipated financial gains from the Transaction, including generating, in the near-term, cash-flows from the Scotia Mine, the inability of Fancamp to raise capital or secure necessary financing in the future, as well as factors discussed in the section entitled “Risks and Uncertainties” in Fancamp’s management’s discussion and analysis of Fancamp’s financial statements for the period ended October 31, 2020. Although Fancamp has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Rajesh Sharma, Interim CEO

+1 (604) 434 8829

info@fancamp.ca

Debra Chapman, Chief Financial Officer

+1 (604) 434 8829

info@fancamp.ca

Media Contact

Hyunjoo Kim

Director, Communication, Marketing & Digital Strategy

Kingsdale Advisors

Phone: 416-867-2357

Cell: 416-899-6463

Email: [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Root, Inc. Investors to Secure Counsel Before Important May 18 Deadline in Securities Class Action – ROOT

NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Root, Inc. (NASDAQ: ROOT) who: (1) purchased or otherwise acquired publicly traded Root securities between October 28, 2020 and March 8, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Root Class A common stock pursuant and/or traceable to the Offering documents issued in connection with the Company’s initial public offering conducted on or about October 28, 2020 (the “IPO” or “Offering”), of the important May 18, 2021lead plaintiff deadline.

SO WHAT: If you purchased Root securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Root class action, go to http://www.rosenlegal.com/cases-register-2061.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Offering documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (2) accordingly, Root would foreseeably require significant cash infusions to meet its cash flow needs; (3) notwithstanding the defendants’ touting of Root’s purportedly unique, data-driven advantages, several of the Company’s established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (4) as a result, the Offering documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Root class action, go to http://www.rosenlegal.com/cases-register-2061.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com



ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – AQST

PR Newswire

NEW YORK, April 1, 2021 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the “Class Period”), of the important April 30, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE:  According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) data included in the Libervant Buccal Film for the management of seizure clusters (“Libervant”) New Drug Application (“NDA”) submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA’s approval prospects; (3) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Libervant NDA in its current form; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content:http://www.prnewswire.com/news-releases/rosen-top-ranked-investor-counsel-encourages-aquestive-therapeutics-inc-investors-to-secure-counsel-before-important-april-30-deadline-in-securities-class-action–aqst-301261107.html

SOURCE Rosen Law Firm, P.A.

BetterInvesting™ Magazine Chooses O’Reilly Automotive Inc. As “Growth” Stock and Masco Corp. As “Undervalued” For June 2021

PR Newswire

TROY, Mich., April 1, 2021 /PRNewswire/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced O’Reilly Automotive Inc. (NASDAQ:ORLY) as its “Stock to Study” and Masco Corp. (NYSE:MAS) is its “Undervalued Stock” in the June/July 2021 issue for investors’ informational and educational use.

“As stimulus checks arrive across the country this week, Americans may be asking if they should invest some of their windfall. Take the time to learn how to invest wisely before jumping in.  Helpful tips at: https://www.betterinvesting.org/learn-about-investing/investor-education/investing/how-to-invest-your-stimulus-check,” said Ken Zendel, the chief executive officer of the National Association of Investors Corp. (NAIC), the parent organization of BetterInvesting.

Check BetterInvesting’s June/July 2021 issue for more details about latest stock selections. Go to the trial version of BetterInvesting’s online tools to study the investment potential of O’Reilly and Masco by viewing their fundamental data and applying judgments.

Committee members are Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; and Walter J. Kirchberger, CFA.

As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.

About BetterInvesting:

BetterInvesting, a national 
501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors Corporation (NAIC), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting is dedicated to providing unbiased, in-depth investing education and powerful online stock analysis tools in order to create successful lifelong investors. BetterInvesting staff along with a dedicated community of volunteers across America teach the organization’s principles and time-tested methodology to both individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org.

Follow us on LinkedIn and Facebook.

Media Contact:
BetterInvesting
1-877-275-6242

Cision View original content:http://www.prnewswire.com/news-releases/betterinvesting-magazine-chooses-oreilly-automotive-inc-as-growth-stock-and-masco-corp-as-undervalued-for-june-2021-301261109.html

SOURCE NAIC-BetterInvesting